While regulators, policymakers and the public appear to be warming up to psychedelics, investment has cooled off significantly in the past year or so. This ‘reality check’ or ‘overdue market correction’ seen in the psychedelics sector is a concentrated reflection of macroeconomic pressures combined with unrealistically rich valuations of early-stage, risky companies. When money dries up…


Previous articleReunion Neuroscience Appoints Robert Alexander as Chief Medical Officer
Next articlePT383 – Identity, Rage, Culture, and Venture Capital